GB9215980D0 - Pharmaceutical spheroid formulation - Google Patents

Pharmaceutical spheroid formulation

Info

Publication number
GB9215980D0
GB9215980D0 GB929215980A GB9215980A GB9215980D0 GB 9215980 D0 GB9215980 D0 GB 9215980D0 GB 929215980 A GB929215980 A GB 929215980A GB 9215980 A GB9215980 A GB 9215980A GB 9215980 D0 GB9215980 D0 GB 9215980D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical
spheroid
formulation
spheroid formulation
pharmaceutical spheroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB929215980A
Other versions
GB2258613B (en
GB2258613A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919117361A external-priority patent/GB9117361D0/en
Priority claimed from GB919122967A external-priority patent/GB9122967D0/en
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Priority to GB9215980A priority Critical patent/GB2258613B/en
Publication of GB9215980D0 publication Critical patent/GB9215980D0/en
Publication of GB2258613A publication Critical patent/GB2258613A/en
Application granted granted Critical
Publication of GB2258613B publication Critical patent/GB2258613B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB9215980A 1991-08-12 1992-07-28 Pharmaceutical diltiazem formulation Expired - Lifetime GB2258613B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9215980A GB2258613B (en) 1991-08-12 1992-07-28 Pharmaceutical diltiazem formulation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919117361A GB9117361D0 (en) 1991-08-12 1991-08-12 Oral dosage form
GB919122967A GB9122967D0 (en) 1991-10-29 1991-10-29 Pharmaceutical composition
GB9215980A GB2258613B (en) 1991-08-12 1992-07-28 Pharmaceutical diltiazem formulation

Publications (3)

Publication Number Publication Date
GB9215980D0 true GB9215980D0 (en) 1992-09-09
GB2258613A GB2258613A (en) 1993-02-17
GB2258613B GB2258613B (en) 1996-01-10

Family

ID=27265807

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9215980A Expired - Lifetime GB2258613B (en) 1991-08-12 1992-07-28 Pharmaceutical diltiazem formulation

Country Status (1)

Country Link
GB (1) GB2258613B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3264722B2 (en) * 1993-02-25 2002-03-11 第一製薬株式会社 Capsule preparation
US7060734B1 (en) 1997-09-09 2006-06-13 Alza Corporation Pharmaceutical coating composition and method of use
JP2001515855A (en) 1997-09-09 2001-09-25 アルザ・コーポレーション Pharmaceutical coating compositions and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
JPS5858146A (en) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd Microcapsule with fast releasability and preparation thereof
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (en) * 1986-09-30 1989-01-05 Valducci Roberto MEMBRANE FOR PHARMACEUTICAL AND INDUSTRIAL USE
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
FR2624732B1 (en) * 1987-12-21 1991-02-15 Synthelabo SUSTAINED RELEASE PHARMACEUTICAL FORMULATION
FR2630647B1 (en) * 1988-04-27 1991-08-16 Sanofi Sa DILTIAZEM MICROBALLS, PROCESS FOR PRODUCING THE SAME, AND SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0373417A1 (en) * 1988-11-30 1990-06-20 Schering Corporation Sustained release diltiazem formulation
IT1241417B (en) * 1990-03-06 1994-01-14 Vectorpharma Int THERAPEUTIC COMPOSITIONS WITH CONTROLLED RELEASE OF DRUGS SUPPORTED ON CROSS-LINKED POLYMERS AND COATED WITH POLYMER FILM, AND THEIR PREPARATION PROCESS

Also Published As

Publication number Publication date
GB2258613B (en) 1996-01-10
GB2258613A (en) 1993-02-17

Similar Documents

Publication Publication Date Title
ZA926019B (en) Pharmaceutical spheroid formulation.
SG55163A1 (en) Pharmaceutical formulations
GB9114950D0 (en) Pharmaceutical formulation
ZA921093B (en) Pharmaceutical formulations
ZA92729B (en) Pharmaceutical agent
GB9001886D0 (en) Pharmaceutical formulation
GB9216061D0 (en) Pharmaceutical combination formulation
GB9215980D0 (en) Pharmaceutical spheroid formulation
GB9121798D0 (en) Pharmaceutical formulation
GB9116467D0 (en) Pharmaceutical formulation
GB9122114D0 (en) Pharmaceutical formulation
GB9122115D0 (en) Pharmaceutical formulation
GB9112974D0 (en) Pharmaceutical formulation
GB9013312D0 (en) Pharmaceutical formulation
IE901206L (en) Pharmaceutical formulation
IE900901L (en) Pharmaceutical formulation
GB9022280D0 (en) Pharmaceutical formulation
GB9019070D0 (en) Pharmaceutical formulation
GB9006650D0 (en) Pharmaceutical formulation
GB9102019D0 (en) Pharmaceutical formulations
GB9125005D0 (en) Pharmaceutical formulations
GB9114621D0 (en) Pharmaceutical formulations
GB9124803D0 (en) Pharmaceutical formulations
GB9103444D0 (en) Pharmaceutical formulations
GB9111858D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20120727